• Which Patients with Early-stage Ulcerative Colitis Have the Worst Prognoses?

Which Patients with Early-stage Ulcerative Colitis Have the Worst Prognoses?

It is a challenge to accurately identify patients with early-stage ulcerative colitis (UC) who are at highest risk for a poor outcome and therefore might require salvage therapy. In a Perspective article in the April issue of Clinical Gastroenterology and Hepatology, Walter Reinisch et al present prognostic factors for adults with newly

Read more

Are Patients Receiving the Latest Anti-HCV Drugs?

Less than 20% of patients infected with the most common Hepatitis C virus (HCV) genotype receive the latest drugs approved by the US Food and Drug Administration (FDA), according to the August issue of Clinical Gastroenterology and Hepatology. This low percentage could result from concerns of side effects or patient

Read more

Many Patients Without GERD Continue to Take PPIs

More than 42% of patients with negative results from pH monitoring studies continue proton pump inhibitor (PPI) therapy, despite evidence that they do not have gastroesophageal reflux disease (GERD), according to the June issue of Clinical Gastroenterology and Hepatology. PPI therapy is effective for about 75% of patients with GERD

Read more